1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow OSU 03012: new trials by email Literature Review of OSU 03012 trials Research Report on OSU 03012
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma AR-12: (2-Amino-N-[4-[5-(2 phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] phenyl]-acetamide) - Solid Tumors, Lymphoma | Phase 1 | Completed | Arno Therapeutics | 35 | 2009-08-01 | 2014-01-29 |
Lymphoma (1)
United Kingdom (1) · United States (1)
James P Thomas, MD PhD (1) · Johann S de Bono, MD PhD (1) · Raoul Tibes, MD PhD (1)